This is to inform you that the Company’s management will be participating in the following group analyst/ investor meetings:
Date Meeting Organized by Location
March 7, 2024 ICICI Securities Limited Hyderabad
Pursuant to Regulation 30 of SEBI Listing Regulations, we wish to inform you that Mr. Ashutosh Kumar Sinha has been appointed as Chief Quality Officer w.e.f. March 6, 2024.
Mr. Sinha holds M.Sc. in Pharmaceutical Chemistry from Institute of Chemists, Kolkata and is an MBA in Total Quality Management (TQM), from Sikkim Manipal University. He brings over 28 years of experience in the Quality function, working across organizations such as
Ranbaxy Labs Ltd, Glenmark Pharma Lab, Dr Reddys Lab and Symbiotec Pharmalab. Prior to joining us he was associated with Syngene International Ltd. as Associate
Vice President & Quality Head (Small molecule & Client dedicated centre).
His area of expertise, within the pharmaceutical Quality, include functions such as Corporate Quality Assurance, Plant Quality Assurance, Development Quality Assurance
(API & Formulation), among others.
| Subscribe To Our Free Newsletter |
